中文别名:
(2R)-1-{4-[(1AR,6R,10BS)-1,1-二氟-1,1A,6,10B-四氢二苯并[A,E]环丙并[C]环庚烯-6-基]哌嗪-1-基}-3-(喹啉-5-基氧基)丙-2-醇三盐酸盐;唑喹达盐酸盐;唑喹达三盐酸盐;ZOSUQUIDAR 三盐酸盐;P-糖蛋白抑制剂(唑喹达三盐酸盐);化合物ZOSUQUIDAR 3HCL;LY 335979; LY-335979; LY335979; D06387; RS33295198; ZOSUQUIDAR HCL; ZOSUQUIDAR 3HCL; ZOSUQUIDAR TRIHYDROCHLORIDE;(R)-1-(4-((1AR,6R,10BS)-1,1-二氟-1,1A,6,10B-四氢二苯并[A,E]环丙烷[C][7]轮烯-6-基)哌嗪-1-基)-3-(喹啉-5-基氧基)丙-2-醇三盐酸盐
英文别名:
Zosuquidar 3HCl;Zosuquidar trihydrochloride, >=98%;Trihydrochloride;Zosuquidar (LY335979) triHydrochloride;D06387;LY 335979; LY-335979; LY335979; D06387; RS33295198;;(αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol trihydrochloride;RS-33295-198; ZOSUQUIDAR; LY-335979